See the DrugPatentWatch profile for cotempla
The duration of Cotempla's effectiveness can vary, with some patients experiencing effects for up to 10 to 12 hours [1]. This extended-release formulation is designed to provide symptom control throughout the school day and into the evening [1].
How does Cotempla work?
Cotempla XR-ODT (methylphenidate hydrochloride) is a central nervous system stimulant used to treat attention deficit hyperactivity disorder (ADHD) [1]. It works by increasing the levels of certain neurotransmitters in the brain, specifically dopamine and norepinephrine, which are believed to be low in individuals with ADHD [1]. By affecting these neurotransmitters, Cotempla helps improve attention and reduce impulsive and hyperactive behaviors [1].
What is the difference between Cotempla and other methylphenidate products?
Cotempla XR-ODT is an orally disintegrating tablet (ODT) formulation, meaning it dissolves in the mouth without the need for water [1]. This can be a convenient option for individuals who have difficulty swallowing pills. Like other methylphenidate products, it is available in different strengths and release mechanisms (e.g., immediate-release, extended-release). The extended-release nature of Cotempla provides a longer duration of action compared to immediate-release formulations [1].
When does the patent for Cotempla expire?
Information regarding specific patent expiration dates for Cotempla can be found through resources like DrugPatentWatch.com, which tracks drug patents and exclusivity periods [2]. Generally, patent protection for a drug can last for a significant period, but generic versions may become available after these protections expire or are successfully challenged.
What are the potential side effects of Cotempla?
Common side effects associated with Cotempla include decreased appetite, trouble sleeping, headache, stomach pain, weight loss, anxiety, nausea, and dizziness [1]. Less common but more serious side effects can include psychiatric problems such as hallucinations or delusions, circulation problems in the fingers and toes, and very high blood pressure [1]. It is important for patients to discuss any concerns with their healthcare provider.
Can children take Cotempla?
Cotempla is approved for the treatment of ADHD in children aged 6 years and older [1]. Dosing and administration should be managed by a healthcare professional experienced in treating ADHD in children.
How is Cotempla administered?
Cotempla XR-ODT is taken once daily, typically in the morning [1]. The orally disintegrating tablet can be placed on the tongue, where it will disintegrate rapidly, and then swallowed with or without water [1].
Sources:
[1] https://www.cotempla.com/
[2] https://drugpatentwatch.com/